Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

INFOGRAPHIC

AZ for $100bn? Pfizer could buy Azerbaijan and keep the change

With Pfizer rumoured to be on the brink of a mega-merger with AstraZeneca, in-Pharmatechnologist.com brings you an interactive view of what £60bn ($101bn) could get.

Related news

News in brief

Hospira has announced US recalls for seven lots of its propofol injection and one lot of 1% Lidocaine HCI Injection due to a glass contamination.

RNA interference (RNAi) developers that saw stock prices fall after Novartis pulled out of the market last week have reiterated their belief in the therapeutic and revenue potential of gene silencing drugs. 

Industry executives have predicted strong growth in pharma R&D and manufacturing, but greater efficiencies could result in fewer US jobs, according to a new survey from PhRMA.

Comments from Novartis, Eli Lilly and Pfizer revealed that industry is taking serious issue with some aspects of the draft guidance from the US FDA on social media and promotional materials online.

Global Industry News

FDA ‘breakthrough’ scheme approves GSK biologic, but is it faster? from BioPharma-Reporter.com

The US Food and Drug Administration (FDA) has approved a second “Breakthrough Therapy” biologic but it is still unclear whether the programme speeds drugs to market, says an expert.

Sanofi sells therapy cells: Aastrom buys products and plants from BioPharma-Reporter.com

Aastrom Biosciences will pay Sanofi $6.5m (EUR4.7m) for its cell therapy business in a deal that gives the cash strapped regenerative medicines developer three commercial products.

AbbVie inks Humira packaging deal as it launches in Saudi Arabia from BioPharma-Reporter.com

AbbVie has teamed up with Arabio for the secondary packaging of its blockbuster biologic Humira as part of a launch into Saudi Arabian market.

Quintiles selects OmniComm for Phase I software from Outsourcing-Pharma.com

CRO Quintiles has signed a five-year agreement to use OmniComm Systems' technology for Phase I clinic automation. 

Clinical trials data: what companies need to know about transparency from Outsourcing-Pharma.com

As the European Medicines Agency (EMA) announces final consultations on its clinical trial data policy will begin at the start of May, we take a look at the issues surrounding trial transparency in Europe.

Spotlight

EMA to rejig variations procedures and industry contact staff in April

EMA to rejig variations procedures and industry contact staff in April

Pharmaceutical firms working in Europe may need to update their address books next month after more reorganisation...

Janssen Button? Will GSK's F1 team up prompt other collaborations?

Janssen Button? Will GSK's F1 team up prompt other collaborations?

GSK has ‘smashed’ production targets at a UK inhaler plant by revving up manufacturing operations with knowhow...

Indian API maker slammed with US FDA Warning over data issues

Indian API maker slammed with US FDA Warning over data issues

Failure in maintaining test and production data has landed an Indian API maker with a Warning Letter...

US FDA issues new bioavailability guidelines

US FDA issues new bioavailability guidelines

The US FDA has published guidance of how sponsors should best document the bioavailability of products for...

Bioavailability breakthrough key to new cancer drug OKed in Japan

Bioavailability breakthrough key to new cancer drug OKed in Japan

Japan has become the first country to approve a new cancer pill that treats disease by interfering...

Key Industry Events

 

Access all events listing

Our events, Events from partners...